378 related articles for article (PubMed ID: 29021228)
1. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Pulsipher MA; Parikh S; Martinez C; Kapoor N; O'Reilly R; Boyer M; Pai SY; Goldman F; Burroughs L; Chandra S; Kletzel M; Thakar M; Connelly J; Cuvelier G; Davila Saldana BJ; Shereck E; Knutsen A; Sullivan KE; DeSantes K; Gillio A; Haddad E; Petrovic A; Quigg T; Smith AR; Stenger E; Yin Z; Shearer WT; Fleisher T; Buckley RH; Dvorak CC
Blood; 2017 Dec; 130(25):2718-2727. PubMed ID: 29021228
[TBL] [Abstract][Full Text] [Related]
2. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Haddad E; Logan BR; Griffith LM; Buckley RH; Parrott RE; Prockop SE; Small TN; Chaisson J; Dvorak CC; Murnane M; Kapoor N; Abdel-Azim H; Hanson IC; Martinez C; Bleesing JJH; Chandra S; Smith AR; Cavanaugh ME; Jyonouchi S; Sullivan KE; Burroughs L; Skoda-Smith S; Haight AE; Tumlin AG; Quigg TC; Taylor C; Dávila Saldaña BJ; Keller MD; Seroogy CM; Desantes KB; Petrovic A; Leiding JW; Shyr DC; Decaluwe H; Teira P; Gillio AP; Knutsen AP; Moore TB; Kletzel M; Craddock JA; Aquino V; Davis JH; Yu LC; Cuvelier GDE; Bednarski JJ; Goldman FD; Kang EM; Shereck E; Porteus MH; Connelly JA; Fleisher TA; Malech HL; Shearer WT; Szabolcs P; Thakar MS; Vander Lugt MT; Heimall J; Yin Z; Pulsipher MA; Pai SY; Kohn DB; Puck JM; Cowan MJ; O'Reilly RJ; Notarangelo LD
Blood; 2018 Oct; 132(17):1737-1749. PubMed ID: 30154114
[TBL] [Abstract][Full Text] [Related]
3. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Thakar MS; Logan BR; Puck JM; Dunn EA; Buckley RH; Cowan MJ; O'Reilly RJ; Kapoor N; Satter LF; Pai SY; Heimall J; Chandra S; Ebens CL; Chellapandian D; Williams O; Burroughs LM; Saldana BD; Rayes A; Madden LM; Chandrakasan S; Bednarski JJ; DeSantes KB; Cuvelier GDE; Teira P; Gillio AP; Eissa H; Knutsen AP; Goldman FD; Aquino VM; Shereck EB; Moore TB; Caywood EH; Lugt MTV; Rozmus J; Broglie L; Yu LC; Shah AJ; Andolina JR; Liu X; Parrott RE; Dara J; Prockop S; Martinez CA; Kapadia M; Jyonouchi SC; Sullivan KE; Bleesing JJ; Chaudhury S; Petrovic A; Keller MD; Quigg TC; Parikh S; Shenoy S; Seroogy C; Rubin T; Decaluwe H; Routes JM; Torgerson TR; Leiding JW; Pulsipher MA; Kohn DB; Griffith LM; Haddad E; Dvorak CC; Notarangelo LD
Lancet; 2023 Jul; 402(10396):129-140. PubMed ID: 37352885
[TBL] [Abstract][Full Text] [Related]
4. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.
Dorsey MJ; Wright NAM; Chaimowitz NS; Dávila Saldaña BJ; Miller H; Keller MD; Thakar MS; Shah AJ; Abu-Arja R; Andolina J; Aquino V; Barnum JL; Bednarski JJ; Bhatia M; Bonilla FA; Butte MJ; Bunin NJ; Chandra S; Chaudhury S; Chen K; Chong H; Cuvelier GDE; Dalal J; DeFelice ML; DeSantes KB; Forbes LR; Gillio A; Goldman F; Joshi AY; Kapoor N; Knutsen AP; Kobrynski L; Lieberman JA; Leiding JW; Oshrine B; Patel KP; Prockop S; Quigg TC; Quinones R; Schultz KR; Seroogy C; Shyr D; Siegel S; Smith AR; Torgerson TR; Vander Lugt MT; Yu LC; Cowan MJ; Buckley RH; Dvorak CC; Griffith LM; Haddad E; Kohn DB; Logan B; Notarangelo LD; Pai SY; Puck J; Pulsipher MA; Heimall J
J Clin Immunol; 2021 Jan; 41(1):38-50. PubMed ID: 33006109
[TBL] [Abstract][Full Text] [Related]
5. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
[TBL] [Abstract][Full Text] [Related]
6. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.
Dvorak CC; Cowan MJ; Logan BR; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Shearer WT; O'Reilly RJ; Fleisher TA; Pai SY; Hanson IC; Pulsipher MA; Fuleihan R; Filipovich A; Goldman F; Kapoor N; Small T; Smith A; Chan KW; Cuvelier G; Heimall J; Knutsen A; Loechelt B; Moore T; Buckley RH
J Clin Immunol; 2013 Oct; 33(7):1156-64. PubMed ID: 23818196
[TBL] [Abstract][Full Text] [Related]
7. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
Cuvelier GDE; Logan BR; Prockop SE; Buckley RH; Kuo CY; Griffith LM; Liu X; Yip A; Hershfield MS; Ayoub PG; Moore TB; Dorsey MJ; O'Reilly RJ; Kapoor N; Pai SY; Kapadia M; Ebens CL; Forbes Satter LR; Burroughs LM; Petrovic A; Chellapandian D; Heimall J; Shyr DC; Rayes A; Bednarski JJ; Chandra S; Chandrakasan S; Gillio AP; Madden L; Quigg TC; Caywood EH; Dávila Saldaña BJ; DeSantes K; Eissa H; Goldman FD; Rozmus J; Shah AJ; Vander Lugt MT; Thakar MS; Parrott RE; Martinez C; Leiding JW; Torgerson TR; Pulsipher MA; Notarangelo LD; Cowan MJ; Dvorak CC; Haddad E; Puck JM; Kohn DB
Blood; 2022 Aug; 140(7):685-705. PubMed ID: 35671392
[TBL] [Abstract][Full Text] [Related]
8. Primary Immune Deficiency Treatment Consortium (PIDTC) report.
Griffith LM; Cowan MJ; Notarangelo LD; Kohn DB; Puck JM; Pai SY; Ballard B; Bauer SC; Bleesing JJ; Boyle M; Brower A; Buckley RH; van der Burg M; Burroughs LM; Candotti F; Cant AJ; Chatila T; Cunningham-Rundles C; Dinauer MC; Dvorak CC; Filipovich AH; Fleisher TA; Bobby Gaspar H; Gungor T; Haddad E; Hovermale E; Huang F; Hurley A; Hurley M; Iyengar S; Kang EM; Logan BR; Long-Boyle JR; Malech HL; McGhee SA; Modell F; Modell V; Ochs HD; O'Reilly RJ; Parkman R; Rawlings DJ; Routes JM; Shearer WT; Small TN; Smith H; Sullivan KE; Szabolcs P; Thrasher A; Torgerson TR; Veys P; Weinberg K; Zuniga-Pflucker JC;
J Allergy Clin Immunol; 2014 Feb; 133(2):335-47. PubMed ID: 24139498
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study.
Miyamoto S; Umeda K; Kurata M; Nishimura A; Yanagimachi M; Ishimura M; Sato M; Shigemura T; Kato M; Sasahara Y; Iguchi A; Koike T; Takahashi Y; Kajiwara M; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
J Clin Immunol; 2021 Nov; 41(8):1865-1877. PubMed ID: 34448087
[TBL] [Abstract][Full Text] [Related]
10. Long term outcomes of severe combined immunodeficiency: therapy implications.
Heimall J; Cowan MJ
Expert Rev Clin Immunol; 2017 Nov; 13(11):1029-1040. PubMed ID: 28918671
[TBL] [Abstract][Full Text] [Related]
11. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
Eissa H; Thakar MS; Shah AJ; Logan BR; Griffith LM; Dong H; Parrott RE; O'Reilly RJ; Dara J; Kapoor N; Forbes Satter L; Chandra S; Kapadia M; Chandrakasan S; Knutsen A; Jyonouchi SC; Molinari L; Rayes A; Ebens CL; Teira P; Dávila Saldaña BJ; Burroughs LM; Chaudhury S; Chellapandian D; Gillio AP; Goldman F; Malech HL; DeSantes K; Cuvelier GDE; Rozmus J; Quinones R; Yu LC; Broglie L; Aquino V; Shereck E; Moore TB; Vander Lugt MT; Mousallem TI; Oved JH; Dorsey M; Abdel-Azim H; Martinez C; Bleesing JH; Prockop S; Kohn DB; Bednarski JJ; Leiding J; Marsh RA; Torgerson T; Notarangelo LD; Pai SY; Pulsipher MA; Puck JM; Dvorak CC; Haddad E; Buckley RH; Cowan MJ; Heimall J
J Allergy Clin Immunol; 2024 Jan; 153(1):287-296. PubMed ID: 37793572
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.
Myers LA; Patel DD; Puck JM; Buckley RH
Blood; 2002 Feb; 99(3):872-8. PubMed ID: 11806989
[TBL] [Abstract][Full Text] [Related]
13. Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.
Horn B; Cowan MJ
J Allergy Clin Immunol; 2013 May; 131(5):1306-11. PubMed ID: 23622119
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
[TBL] [Abstract][Full Text] [Related]
16. Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution.
Delmonte OM; Castagnoli R; Yu J; Dvorak CC; Cowan MJ; Dávila Saldaña BJ; De Ravin SS; Mamcarz E; Chang CK; Daley SR; Griffith LM; Notarangelo LD; Puck JM
J Allergy Clin Immunol; 2022 Mar; 149(3):1113-1119. PubMed ID: 34384841
[TBL] [Abstract][Full Text] [Related]
17. Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency.
Lum SH; Elfeky R; Achini FR; Margarit-Soler A; Cinicola B; Perez-Heras I; Nademi Z; Flood T; Cheetham T; Worth A; Qasim W; Amin R; Rao K; Chiesa R; Bredius RGM; Amrolia P; Abinun M; Hambleton S; Veys P; Gennery AR; Lankester A; Slatter M
J Clin Immunol; 2021 Jan; 41(1):171-184. PubMed ID: 33141919
[TBL] [Abstract][Full Text] [Related]
18. Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation.
Labrosse R; Boufaied I; Bourdin B; Gona S; Randolph HE; Logan BR; Bourbonnais S; Berthe C; Chan W; Buckley RH; Parrott RE; Cuvelier GDE; Kapoor N; Chandra S; Dávila Saldaña BJ; Eissa H; Goldman FD; Heimall J; O'Reilly R; Chaudhury S; Kolb EA; Shenoy S; Griffith LM; Pulsipher M; Kohn DB; Notarangelo LD; Pai SY; Cowan MJ; Dvorak CC; Haddad É; Puck JM; Barreiro LB; Decaluwe H
J Allergy Clin Immunol; 2023 Jan; 151(1):260-271. PubMed ID: 35987350
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
Knutsen AP; Wall DA
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
[TBL] [Abstract][Full Text] [Related]
20. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
Front Immunol; 2019; 10():1997. PubMed ID: 31507601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
